Brain, Vol. 122, No. 8, 1579-1587,
August 1999
© 1999 Oxford University Press
Differential expression of matrix metalloproteinases in bacterial meningitis
1 Department of Neurology, Karl-Franzens-Universität, Graz, Austria, 2 Department of Neurology, Ludwig-Maximilians-Universität, München, Germany and 3 British Biotech Pharmaceuticals Limited, Oxford, UK
Correspondence to:
Dr Bernd C. Kieseier, Department of Neurology, Karl-Franzens-Universität, Auenbruggerplatz 22, 8036 Graz, Austria E-mail: bc.kieseier{at}kfunigraz.ac.at
Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of various inflammatory diseases of the central nervous system. Evidence is accumulating that gelatinase B (MMP-9) might be involved in the pathogenesis of meningitis, but the spectrum of different MMPs involved in the inflammatory reaction of this disease has not been determined. We investigated the temporal and spatial mRNA expression pattern of gelatinase B in experimental meningococcal meningitis in rats. In contrast to controls, increased mRNA levels with peak values 6 h after injection with menigococci were found in brain specimens of the animals. Elevated MMP-9 mRNA expression was accompanied by enhanced proteolytic activity, as demonstrated by gelatin zymography, and positive immunoreactivity. The mRNA expression pattern of six other MMPs was investigated. Collagenase-3 and stromelysin-1 mRNAs were also found to be upregulated. In contrast, mRNA levels for gelatinase A, matrilysin, stromelysin-2 and stromelysin-3 remained unchanged. As evidenced by significantly increased intracranial pressure and by leakage of intravenously injected Evans blue through the blood vessel walls into the brain parenchyma, the animals injected with meningococci revealed signs of blood–brain barrier disruption. Augmented proteolytic activity of MMP-9 could also be demonstrated in CSF samples obtained from patients with bacterial meningitis, underlining the clinical relevance of our experimental findings. Our data indicate that gelatinase B, collagenase-3 and stromelysin-1 are selectively upregulated in bacterial meningitis and thus may contribute to the pathogenesis of this infectious disease of the central nervous system.
gelatinase B; collagenase-3; stromelysin-1; bacterial meningitis; experimental meningitis
MMP = matrix metalloproteinase; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; TNF-
= tumour necrosis factor-; WBC = white blood cell
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Hoffman and J. R. Weber Review: Pathophysiology and treatment of bacterial meningitis Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 401 - 412. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Colicchio, S. Ricci, F. Lamberti, C. Pagliarulo, C. Pagliuca, V. Braione, T. Braccini, A. Tala, D. Montanaro, S. Tripodi, et al. The Meningococcal ABC-Type L-Glutamate Transporter GltT Is Necessary for the Development of Experimental Meningitis in Mice Infect. Immun., September 1, 2009; 77(9): 3578 - 3587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Tsai, L.-Y. Chung, E.-R. Chen, Y.-C. Liu, S. S.-J. Lee, Y.-S. Chen, C.-L. Sy, S.-R. Wann, and C.-M. Yen Association of Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-4 in Cerebrospinal Fluid with Blood-Brain Barrier Dysfunction in Patients with Eosinophilic Meningitis Caused by Angiostrongylus cantonensis Am J Trop Med Hyg, January 1, 2008; 78(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Paul, U. Koedel, F. Winkler, B. C. Kieseier, A. Fontana, M. Kopf, H.-P. Hartung, and H.-W. Pfister Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis Brain, August 1, 2003; 126(8): 1873 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Winkler, S. Kastenbauer, U. Koedel, and H. W. Pfister Role of the urokinase plasminogen activator system in patients with bacterial meningitis Neurology, November 12, 2002; 59(9): 1350 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kastenbauer, U. Koedel, B. F. Becker, and H. W. Pfister Oxidative stress in bacterial meningitis in humans Neurology, January 22, 2002; 58(2): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Asahi, X. Wang, T. Mori, T. Sumii, J.-C. Jung, M. A. Moskowitz, M. E. Fini, and E. H. Lo Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood-Brain Barrier and White Matter Components after Cerebral Ischemia J. Neurosci., October 1, 2001; 21(19): 7724 - 7732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-T. Khuth, H. Akaoka, A. Pagenstecher, O. Verlaeten, M.-F. Belin, P. Giraudon, and A. Bernard Morbillivirus Infection of the Mouse Central Nervous System Induces Region-Specific Upregulation of MMPs and TIMPs Correlated to Inflammatory Cytokine Expression J. Virol., September 1, 2001; 75(17): 8268 - 8282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Leib, J. M. Clements, R. L. P. Lindberg, C. Heimgartner, J. M. Loeffler, L.-A. Pfister, M. G. Tauber, and D. Leppert Inhibition of matrix metalloproteinases and tumour necrosis factor {alpha} converting enzyme as adjuvant therapy in pneumococcal meningitis Brain, September 1, 2001; 124(9): 1734 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Price, J. Farrar, T. T. H. Chau, N. T. H. Mai, T. T. Hien, and J. S. Friedland Identification of a Matrix-Degrading Phenotype in Human Tuberculosis In Vitro and In Vivo J. Immunol., March 15, 2001; 166(6): 4223 - 4230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Michel, R. Zobotke, M. Mader, and R. Nau Regulation of Matrix Metalloproteinase Expression in Endothelial Cells by Heat-Inactivated Streptococcus pneumoniae Infect. Immun., March 1, 2001; 69(3): 1914 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Leib, D. Leppert, J. Clements, and M. G. Tauber Matrix Metalloproteinases Contribute to Brain Damage in Experimental Pneumococcal Meningitis Infect. Immun., February 1, 2000; 68(2): 615 - 620. [Abstract] [Full Text] [PDF]
|
|